MIM
GTHX

Monashee Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Monashee Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Hold
0
– – – 14
2018
Q2 		– Sell
-68,000
Closed -$2.52M – 212
2018
Q1 		$2.52M Buy
+68,000
New +$1.81M 0.7% 40
2017
Q3 		– Sell
-45,110
Closed -$787K – 122
2017
Q2 		$787K Buy
+45,110
New +$789K 0.33% 62

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Monashee Investment Management's GTHX Position: Q3 2018 in Review

Monashee Investment Management held its G1 Therapeutics, Inc. Common Stock (GTHX) position steady in Q3 2018 at 0 shares worth $8.11M. The position accounts for 1.72% of the portfolio, ranked #14.

Monashee Investment Management first reported a position in GTHX in Q2 2017 and has held it in 2 quarters since. The position peaked at $2.52M in Q1 2018. 115 funds tracked by Wall St. Rank hold GTHX as of Q3 2018.

  • Monashee Investment Management held 0 shares of G1 Therapeutics, Inc. Common Stock worth $8.11M as of Q3 2018.
  • Monashee Investment Management left its G1 Therapeutics, Inc. Common Stock share count unchanged in Q3 2018.
  • G1 Therapeutics, Inc. Common Stock made up 1.72% of Monashee Investment Management's portfolio in Q3 2018, its #14 holding.
  • Monashee Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and has held it in 2 quarters since.
  • Monashee Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $2.52M in Q1 2018.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2018.

Based on Monashee Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.